GB0024446D0 - Protein - Google Patents
ProteinInfo
- Publication number
- GB0024446D0 GB0024446D0 GBGB0024446.7A GB0024446A GB0024446D0 GB 0024446 D0 GB0024446 D0 GB 0024446D0 GB 0024446 A GB0024446 A GB 0024446A GB 0024446 D0 GB0024446 D0 GB 0024446D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0024446.7A GB0024446D0 (en) | 2000-10-05 | 2000-10-05 | Protein |
GB0124032A GB2371303A (en) | 2000-10-05 | 2001-10-05 | Receptor polypeptides with immunomodulatory activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0024446.7A GB0024446D0 (en) | 2000-10-05 | 2000-10-05 | Protein |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0024446D0 true GB0024446D0 (en) | 2000-11-22 |
Family
ID=9900755
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0024446.7A Ceased GB0024446D0 (en) | 2000-10-05 | 2000-10-05 | Protein |
GB0124032A Withdrawn GB2371303A (en) | 2000-10-05 | 2001-10-05 | Receptor polypeptides with immunomodulatory activity |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0124032A Withdrawn GB2371303A (en) | 2000-10-05 | 2001-10-05 | Receptor polypeptides with immunomodulatory activity |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB0024446D0 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10303974A1 (en) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid β (1-42) oligomers, process for their preparation and their use |
JP5486808B2 (en) | 2005-11-30 | 2014-05-07 | アッヴィ・インコーポレイテッド | Monoclonal antibody against amyloid beta protein and use thereof |
PL1954718T3 (en) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
CN104744591B (en) | 2010-04-15 | 2022-09-27 | Abbvie德国有限责任两合公司 | Amyloid beta binding proteins |
CN105348387B (en) | 2010-08-14 | 2020-08-25 | Abbvie 公司 | Amyloid beta binding proteins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000043513A1 (en) * | 1999-01-21 | 2000-07-27 | Millennium Pharmaceuticals, Inc. | 17723 receptor, a g-protein coupled receptor |
JP2003530833A (en) * | 2000-03-29 | 2003-10-21 | ノバルティス アクチエンゲゼルシャフト | Organic compounds |
-
2000
- 2000-10-05 GB GBGB0024446.7A patent/GB0024446D0/en not_active Ceased
-
2001
- 2001-10-05 GB GB0124032A patent/GB2371303A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB0124032D0 (en) | 2001-11-28 |
GB2371303A (en) | 2002-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0001704D0 (en) | Protein | |
GB0003079D0 (en) | Novel protein | |
GB0011185D0 (en) | Protein | |
GB0124032D0 (en) | Protein | |
GB0027905D0 (en) | New protein | |
GB0009181D0 (en) | Protein | |
GB0025677D0 (en) | New protein | |
IL150774A0 (en) | Apoptin-associating protein | |
EP1323734A4 (en) | Irap-binding protein | |
EP1179592A4 (en) | Proteins nectin-3 | |
GB0008549D0 (en) | Protein | |
GB0020345D0 (en) | Protein | |
GB0101892D0 (en) | Novel protein | |
GB0030186D0 (en) | Protein | |
GB0030294D0 (en) | Protein | |
GB0015307D0 (en) | Protein | |
GB0011056D0 (en) | Protein | |
GB0008774D0 (en) | Protein | |
GB0001709D0 (en) | Protein | |
GB0001708D0 (en) | Protein | |
GB0031341D0 (en) | Protein | |
GB0014825D0 (en) | Protein | |
GB0027308D0 (en) | Drug-activated proteins | |
GB0014158D0 (en) | New protein | |
GB0010596D0 (en) | New protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |